Involvement of Purinergic Neurotransmission in Ketamine Induced Bladder Dysfunction
The DOI matches its Crossref record.
Abstract
PURPOSE: Long-term ketamine abuse in humans causes significant lower urinary tract symptoms. However, the etiology of ketamine associated cystitis is still not clear. We created a mouse model of ketamine induced lower urinary tract dysfunction to explore the pathogenesis of this condition. MATERIALS AND METHODS: Female C57BL/6 mice randomly distributed into control and ketamine groups received daily intraperitoneal injection of saline and ketamine (100 mg/kg), respectively. Cystometry was done in each group at 4, 8 and 16 weeks. After sacrifice the bladders were harvested for isometric muscle tension recording and immunohistochemical examination. RESULTS: After 8 weeks of treatment body weight growth was significantly decreased in ketamine treated mice. Cystometry revealed a significantly decreased intercontraction interval (mean±SEM 237±9 vs 360±20 seconds, p<0.001) and decreased bladder capacity (0.1±0.004 vs 0.13±0.006 ml, p<0.001) in ketamine vs saline injected mice. Increased adenosine triphosphate evoked detrusor contraction developed in the ketamine group. Immunohistochemical examination revealed increased P2X1 receptor expression in ketamine treated mouse bladders while M2 and M3 receptor expression was unchanged. CONCLUSIONS: At 8 weeks mice treated with ketamine showed increased voiding frequency and decreased bladder capacity, the same symptoms that develop in human ketamine abusers. Enhanced noncholinergic contractions and P2X1 receptor expression in the ketamine bladder indicate that dysregulation of purinergic neurotransmission may underlie detrusor overactivity in cases of ketamine induced bladder dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Ketamine Pharmacology: An Update ( Pharmacodynamics and Molecular Aspects, Recent Findings )
Mion, G., & Villevieille, T. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12099 · Cited by 711
“Some ketamine effects involve the purinergic system, like toxic effects on the urinary tract [81].”
BackgroundPossible pathophysiology of ketamine‐related cystitis and associated treatment strategies
Jhang, J., Hsu, Y., & Kuo, H. (2015) · International Journal of Urology · doi:10.1111/iju.12841 · Cited by 106
Clinical staging of ketamine-associated urinary dysfunction: a strategy for assessment and treatment
Wu, P., Wang, Q., Huang, Z., Wang, J., Wu, Q., & Lin, T. (2016) · World Journal of Urology · doi:10.1007/s00345-016-1759-9 · Cited by 28
Risk Factors of Lower Urinary Tract Syndrome among Ketamine Users
CHEN, I., LEE, M., CHEN, W., HU, T., & LIN, H. (2018) · LUTS: Lower Urinary Tract Symptoms · doi:10.1111/luts.12178 · Cited by 16
Metadata
- Authors
- Meng, E., Chang, H.-Y., Chang, S.-Y., Sun, G.-H., Yu, D.-S., & Cha, T.-L.
- Venue
- Journal of Urology
- Published
- 2011-09
- Volume
- 186
- Issue
- 3
- Pages
- 1134-1141
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2019370739
- Cited by
- 76
- References
- 0
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Involvement of Purinergic Neurotransmission in Ketamine Induced Bladder Dysfunction. https://app.cochat.ai/papers/10.1016/j.juro.2011.04.102
- The paper
- Meng, E., Chang, H.-Y., Chang, S.-Y., Sun, G.-H., Yu, D.-S., & Cha, T.-L. (2011). Involvement of Purinergic Neurotransmission in Ketamine Induced Bladder Dysfunction. Journal of Urology. https://doi.org/10.1016/j.juro.2011.04.102
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.